Modeling and Simulation - PK/PD Archives | Page 8 of 37 | Certara

Brochure

Pirana Modeling Workbench

Pirana is a flexible and extendible modeling workbench with an intuitive graphical user interface for…

CertaraMay 28, 2019

Poster

Population Pharmacokinetic Analysis of DS-8201a, A HER2-Targeting Antibody-Drug Conjugate, in Patients with HER2-Positive Breast Cancer or Other Solid Tumors

CertaraMay 2, 2019

Poster

Simulating the Impact of the Interplay Between CYP2C19 Polymorphisms and Ethnicity on Response to Clopidogrel, Using PBPK-PD Models

CertaraApril 22, 2019

Poster

Exposure-Response Analyses to Support Dose Justification of DS-8201A, A HER2-Targeting Antibody-Drug Conjugate, in HER2-Positive Breast Cancer Patients

CertaraApril 22, 2019

Poster

Relationship of Ivosidenib Plasma Concentration to Heart Rate-Corrected QT Interval in Patients with IDH1-Mutant Advanced Hematologic Malignancies

CertaraApril 22, 2019

Poster

Validation of the Pharmacokinetic/Pharmacodynamic Model Used for Dose Selection of Andexanet Alfa for Reversal of Anticoagulation

CertaraApril 22, 2019

On-Demand Webinar

How to Perform IVIVC for Extremely Long Acting Drugs

Watch this webinar to learn how to use in vitro and in vivo models to…

CertaraFebruary 22, 2019

Poster

Automated Average Bioequivalence Analysis with Additional Metrics and Statistics to Meet the FDA Guidance on Methylphenidate Hydrochloride Using Phoenix WinNonlin

CertaraNovember 4, 2018

On-Demand Webinar

How to Use a Reference-scaled Average Bioequivalence Approach for Narrow Therapeutic Index Drugs

Watch this webinar to learn how RSABE for NTIDs can be performed in Phoenix WinNonlin…

CertaraSeptember 25, 2018

Brochure

Certara Professional Certification Program

Certara Professional Certification is an online accreditation of user competency and proficiency in analysis of…

CertaraAugust 21, 2018

© 2025 Certara. All Rights Reserved. | Privacy policy